CyberKnife® for Pancreatic Tumors
CyberKnife® for Pancreatic Tumors
CyberKnife treats pancreatic cancer with high-dose radiation. Clinical studies are ongoing to test the CyberKnife’s effectiveness in treating localized, non-metastatic pancreatic cancer. However, preliminary results involving patients with relatively advanced cases of pancreatic cancer suggest that CyberKnife radiosurgery treatment is well tolerated and provides some clinical benefit.
Prior to treatment, doctors implant between three to five small metal markers known as fiducials in or near the tumor that enable the CyberKnife to pinpoint the tumor location throughout treatment. Implanting the markers is an outpatient procedure that takes about an hour. About a week later, patients are fitted with a custom body mold made of soft material that they lie on during treatments. The fitting process is painless. Patients then undergo a CT scan that assists in developing a customized treatment plan.
CYBERKNIFE STEREOTACTIC RADIOSURGERY FOR PANCREATIC CANCER
The patient is a 68 year old male diagnosed with pancreatic head adenocarcinoma measuring 2.9 x 3.4 cm after experiencing lower back pain and a recent weight loss of over 40 pounds over the previous 6 months. After consultation the patient decided on CyberKnife treatment of the mass.
Key Advantages of CyberKnife for Pancreatic Tumors
Patient Resource Tools
Speak with one of our dedicated team members about how we can help today.